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Abstract
In contrast to the definitive role of the transcription factor, CCAAT/Enhancer binding protein a (C/EBPa), in steady-state
granulopoiesis, previous findings have suggested that granulopoiesis during emergency situations, such as infection, is
dependent on C/EBPb. In this study, a novel lentivirus-based reporter system was developed to elucidate the molecular
switch required for C/EBPb-dependency. The results demonstrated that two cyclic AMP responsive elements (CREs) in the
proximal promoter region of C/EBPb were involved in the positive regulation of C/EBPb transcription during granulocyte-
macrophage colony-stimulating factor (GM-CSF)–induced differentiation of bone marrow cells. In addition, the transcripts of
CRE binding (CREB) family proteins were readily detected in hematopoietic stem/progenitor cells. CREB was upregulated,
phosphorylated and bound to the CREs in response to GM-CSF stimulation. Retroviral transduction of a dominant negative
CREB mutant reduced C/EBPb mRNA levels and significantly impaired the proliferation/differentiation of granulocyte
precursors, while a constitutively active form of CREB facilitated C/EBPb transcription. These data suggest that CREB proteins
are involved in the regulation of granulopoiesis via C/EBPb upregulation.
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Introduction
Steady state granulopoiesis is a continuous process in which
hematopoietic stem cells give rise to constant numbers of
granulocytes, which are supplied to peripheral blood and various
tissues [1]. During emergency situations such as infection, the
supply of sufficient numbers of granulocytes to the front line is a
prerequisite for the host defense. Under such a stressed condition,
in addition to the mobilization of granulocytes from peripheral
pools, granulopoiesis must be enhanced to meet immediate
demands as granulocytes have a short half-life. Previous findings
have suggested that, in steady-state conditions, granulopoiesis is
dependent on the transcription factor CCAAT enhancer binding
protein a (C/EBPa) [2,3], whereas in emergency situations,
granulopoiesis is dependent on C/EBPb [4,5]. Indeed, in response
to cytokine stimulation or infection, the transcripts of C/EBPa
were down-regulated in granulocyte precursors, while the tran-
scripts of C/EBPb were upregulated [4]. Both C/EBPa and C/
EBPb can induce granulocytic differentiation [4,6], but the
inhibitory effects of C/EBPa on cell cycle is much stronger than
those of C/EBPb [7,8,9]. This suggests a critical function for C/
EBPb in emergency granulopoiesis, which demands both differ-
entiation and proliferation of granulocyte precursors. However,
the molecular mechanisms involved in the shift from C/EBPa
dependency to C/EBPb dependency remain to be elucidated. In
this study, a novel lentivirus vector-based reporter system was
devised for monitoring the activity of a promoter of interest. This
method was used to analyze the proximal promoter region of C/
EBPb and revealed the involvement of the cyclic AMP responsive
element-binding (CREB) family of transcription factors in the
regulation of emergency granulopoiesis through the transcriptional
upregulation of C/EBPb.
Results
Monitoring of Promoter Activity by a Lentivirus-based
Reporter System
When GM-CSF was intraperitoneally administered to mice
in vivo (10 mg/kg62), C/EBPb mRNA in c-kit
+ bone marrow cells
was upregulated approximately two-fold 48 hours after the
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e54862injection (Figure 1A). This result, together with our previous
observation [4], suggested that C/EBPb is activated, at least
partly, at the transcriptional level. The differentiation and
proliferation of hematopoietic stem/progenitor cells are compli-
cated processes, which are hard to mimic in cell lines; therefore,
we established a system that allowed us to monitor the activity of a
promoter of interest in primary cells. For this purpose, we took
advantage of lentivirus vectors, which can be transduced into
quiescent cells and easily applicable to human hematopoietic stem
cells in the future. The two expression units shown in Figure 1B, a
d2EGFP gene driven by a promoter of interest and a mouse
Thy1.1 gene under the control of a constitutively-active PGK
promoter, were cloned into a lentivirus vector. An insulator
sequence from sea urchin arylsulfatase, Ars I [10], was cloned into
the 39 self-inactivated long terminal repeat of the vector to avoid
integration site effects on promoter activity [11]. In this system, the
activity of the promoter of interest will be reflected by the intensity
of the d2EGFP signal within Thy1.1
+ cells. To confirm the
usefulness of this vector, bone marrow cells were transduced with
the lentivirus vector with or without the elongation factor-1 (EF-1)
promoter in front of the d2EGFP gene. EF-1 promoter activity
was then assessed by flow cytometry 48 hours after the
transduction (Figure 1C). As shown in the right panel, the
expression level of d2EGFP within Thy1.1
+ cells was enhanced
strongly in the presence of the EF-1 promoter, confirming that this
lentiviral system enabled us to monitor the activity of a promoter
in mouse bone marrow cells.
Figure 1. Lentivirus-based reporter system. A. Expression of C/EBPb mRNA in c-kit
+ bone marrow cells with or without GM-CSF stimulation
in vivo.* : P,0.05, n=3. Data are representative of two independent experiments. B. Schematic illustration of the lentivirus vector for reporter assays.
SIN, self-inactivated long terminal repeat; PGK prom, phosphoglycerate kinase promoter; Ars I, sea urchin arylsulfatase insulator sequence. C.
Elongation factor-1 (EF-1) promoter activity in bone marrow cells revealed by the lentivirus-based reporter system. Bone marrow cells were analyzed
by flow cytometry after two days incubation with GM-CSF following viral infection. Shaded histogram, promoter-less control; open histogram, EF-1
promoter.
doi:10.1371/journal.pone.0054862.g001
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PLOS ONE | www.plosone.org 2 January 2013 | Volume 8 | Issue 1 | e54862Figure 2. Flow cytometric analysis of the C/EBPb proximal promoter region using the lentivirus-based reporter system. A. Schematic
illustration of the lentivirus vector. SIN, self-inactivated long terminal repeat; PGK prom, phosphoglycerate kinase promoter; Ars I, sea urchin
arylsulfatase insulator sequence. B and C. Bone marrow cells were transduced with the lentivirus vector containing the indicated fragment and were
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and 243 bp Upstream of the C/EBPb Gene
The proximal promoter region of the C/EBPb gene was
assessed using the lentiviral system mentioned above (Figure 2A).
A 1106-bp genomic fragment (between 21093 and +16 bp) was
cloned into the lentivirus vector and the promoter activity was
investigated in GM-CSF–stimulated bone marrow cells. A shift in
d2EGFP expression was observed in the presence of wild-type C/
EBPb promoter sequences (Figure 2B, top panel). Accordingly, the
mean fluorescent intensity (MFI) was increased from 3.460.4 to
4.660.2 (p,0.05, n=3, Figure 2C). When deletion variants of the
genomic fragment were analyzed, the promoter activity was
severely abrogated (MFI: from 4.760.1 to 3.760.1, p,0.05,
n=3), particularly when the fragment between 2243 bp and
243 bp was deleted, suggesting the existence of positive regulatory
elements within this region (Figure 2B, bottom panel and
Figure 2C). A computational search for transcription factor
consensus sequences within this region revealed two tandemly-
aligned cyclic AMP responsive elements (CREs). To assess the
function of these CREs with respect to the promoter activity, each
CRE element (at 2110 bp and 265 bp) was mutated using site-
directed mutagenesis (Figure 2D). While the mutation in the CRE
at 2110 bp resulted in a slight but significant reduction of the
promoter activity (MFI: from 4.760.1 to 4.360.1, p,0.05), the
mutation in the CRE at 265 bp more efficiently impaired the
promoter activity (MFI: from 4.760.1 to 3.360.1, p,0.01, n=3,
Figure 2D and E), suggesting that the CREs, especially the one at
265 bp, are important in mediating the response of the promoter
to GM-CSF stimulation.
CREBs in Myeloid Progenitors are Activated in Response
to GM-CSF
CRE is the consensus binding site for the CREB family of
transcription factors which include CREB, ATF1 and CREM
[12]. Firstly, the mRNA expression levels for these three proteins
were measured in c-kit
+ Sca-1
+ lineage
2 hematopoietic stem cells
(HSCs), common myeloid progenitors (CMPs), granulocyte-
macrophage progenitors (GMPs), megakaryocyte-erythrocyte pro-
genitors (MEPs) and Gr-1
+ mature granulocytes. Expression level
of all three CREB family members were gradually decreased
during the differentiation of HSCs to GMPs through CMPs, while
the expression levels in mature granulocytes varied between the
three factors (Figure 3A). MEPs expressed the transcripts of all
these family members at higher level than GMPs (Figure 3A).
These results are consistent with previous observations by Cheng
JC et al. showing that CREB was highly expressed in immature
hematopoietic cells [13]. CREB proteins are activated by the
phosphorylation of specific residues, which leads to the recruit-
ment of transcriptional coactivators and the activation of target
gene transcription through binding to CREs [14,15,16]. When
bone marrow cells were stained with a fluorescent-conjugated anti-
phospho CREB-specific antibody, the intensity of the fluorescence
within c-kit
+ cells shifted after stimulation with GM-CSF (MFI:
from 57.668.0 to 78.966.9, p,0.05, n=3, Figure 3B), suggesting
that phosphorylated CREB was induced by GM-CSF. Western
blotting of c-kit
+ cells before and after stimulation with GM-CSF
showed the increase of both phosphorylated form and total CREB,
suggesting that GM-CSF induced upregulation of overall amount
of CREB (Figure 3C). Then, CREB protein binding to the CREs
in the promoter region of C/EBPb was assessed by chromatin
immunoprecipitation using an anti-CREB antibody (Figure 3D).
When a primer pair flanking both of the CREs was used to amplify
the immunoprecipitated chromatin, the amount of the amplified
product was enhanced in the presence of GM-CSF (Figure 3D). In
addition, gel shift experiments were performed (Figure 3E).
Nuclear extracts of 293T cells transduced with constitutively-
active (CREB
DIEDML) CREB [14] showed binding to both of the
CREs. Addition of non-labeled oligonucleotide corresponding to
CREB consensus sites abolished the binding and preincubation
with anti-CREB antibody diminished the shifted bands. Taken
together, these results suggested that the CREB proteins were
expressed readily in hematopoietic stem/progenitor cells, upregu-
lated and phosphorylated in response to GM-CSF, and bound to
the CRE sites in the promoter region of C/EBPb.
Involvement of CREB Proteins in Cytokine-stimulated
Granulopoiesis and C/EBPb Upregulation
To see the effects of CREB proteins on granulocytic differen-
tiation and C/EBPb mRNA expression, the dominant-negative
(CREB
S133A) [17] or constitutively-active (CREB
DIEDML) [14]
CREB mutants were fused to the ligand-binding domain of the
estrogen receptor and were transduced into bone marrow cells
from 5-fluorouracil treated mice using a bicistronic retroviral
vector expressing GFP. Nuclear translocation of these fusion
proteins in response to hydroxytamoxifen was confirmed by
Western blotting of nuclear extracts from the transduced cell line
(Figure 4A). The transduced bone marrow cells were cultured for a
further 48 hours with GM-CSF in the presence or absence of
hydroxytamoxifen. As shown in Figure 4B (middle panel) and 4C,
treatment with hydroxytamoxifen significantly reduced the GFP
+
Gr-1
+ cells when the dominant negative CREB mutant
(CREB
S133A) was transduced, whereas it had no significant effect
following the transduction of the control vector or a vector
expressing the constitutively active CREB
DIEDML (Figure 4B, left
and right panels, respectively). The GFP
+Gr-1
+ cells from these
experiments were then subjected to quantitative RT-PCR. The
introduction of the CREB
S133A mutant repressed C/EBPb mRNA
expression significantly, whereas CREB
DIEDML upregulated C/
EBPb by almost two-fold (p,0.05) (Figure 4D, left panel). Nuclear
translocation of either CREB
DIEDML or CREB
S133A downregu-
lated the endogenous CREB protein and resulted in upregulation
or downregulation of C/EBPb protein, respectively (Figure 4E).
Then we measured the expression levels of putative targets of C/
EBPb. CREB
S133A mutant significantly downregulated the tran-
scripts of G-CSF receptor and myeloperoxidase. In contrast,
CREB
DIEDML did not affect the expression of these genes. These
results suggested that CREBs are involved in the cytokine-
stimulated granulopoiesis through the upregulation of C/EBPb.
In order to verify that CREB mediated upregulation of C/
EBPb is involved in emergency granulopoiesis, a fungus infection
experiment was carried out. Tail vein injection of Candida albicans
causes enhanced granulopoiesis [4,18,19]. c-kit
+ cells were purified
from bone marrow harvested on day 2 after infection and
subjected to quantitative RT-PCR. C/EBPb mRNA was
upregulated approximately two-fold (Figure 5A). CREB was
upregulated at protein level and binding of CREB to the promoter
region of C/EBPb containing the CREs was also enhanced as
analyzed for Thy1.1 and d2EGFP expression after 48 hours stimulation with GM-CSF. D and E. Effects of the mutated CREs at 2110 and 265 bp on the
activity of the promoter fragment (2243 to +16 bp). Shaded histogram, promoter-less control; open histogram, promoter fragment. Wt, wild type;
mut, mutated. *:P,0.05, **:P,0.01 (n=3). Data are representative of three independent experiments.
doi:10.1371/journal.pone.0054862.g002
Involvement of CREBs in Emergency Granulopoiesis
PLOS ONE | www.plosone.org 4 January 2013 | Volume 8 | Issue 1 | e54862Figure 3. Expression and activation of CREB proteins in myeloid progenitors. A. CREB family member mRNA expression in purified
hematopoietic populations. HSC, hematopoietic stem cells; CMP, common myeloid progenitor; GMP, granulocyte-macrophage progenitor; MEP,
megakaryocyte-erythrocyte progenitor. B. Phosphorylation of CREB in response to GM-CSF. Left panels: expression of c-kit and phosphorylated CREB
with or without GM-CSF stimulation. The expression of phosphorylated CREB within c-kit
+ cells is shown in the right panel. Shaded histogram,
without GM-CSF; open histogram, with GM-CSF. C. Western blotting analysis of c-kit+ bone marrow cells with or without stimulation with GM-CSF. D.
Chromatin immunoprecipitation of CREB using bone marrow cells during GM-CSF–induced differentiation in vitro. E. Gel shift analysis with CREs in
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(Figure 5B and 5C), suggesting that CREB-C/EBPb pathway is
activated in candidemia-induced emergency granulopoiesis.
Discussion
The activation of C/EBPb is controlled at multiple steps, from
transcription and translation through to post-translational modi-
fications, in response to various different stimuli [20]. This study
has focused on the analysis of C/EBPb transcriptional regulation
during GM-CSF–induced granulocytic differentiation using a
lentivirus-based reporter assay system developed for the purpose,
and the results clearly demonstrated that members of the CREB
family of transcription factors are involved in regulating the
transcription of C/EBPb during cytokine-stimulated granulopoi-
esis.
Sakamoto and colleagues have investigated the role of CREB in
hematopoiesis intensively. They showed that CREB levels are
elevated in normal immature bone marrow cells and blast cells
from patients with acute myeloid leukemia [13,21]. Transgenic
mouse lines expressing CREB under the control of the myeloid
specific MRP8 promoter developed myeloproliferative syndrome
with splenomegaly [21], while the knockdown of CREB using
siRNAs resulted in the decreased proliferation of normal and
leukemic hematopoietic stem/progenitor cells [13]. Pigazzi et al.
also have shown that dysregulation of CREB was involved in the
pathogenesis of leukemia [22,23]. These results clearly suggest that
CREB proteins play important roles in the proliferation and
differentiation of normal and malignant myeloid cells. In this
study, a dominant negative mutant of CREB downregulated the
expression level of C/EBPb and decreased the Gr-1
+ granulocytes
(Figure 4). These results suggested that CREBs are also involved in
the cytokine-stimulated granulopoiesis and that C/EBPb is one of
the downstream targets of CREB. When a constitutively active
CREB was transduced, increase of Gr-1
+ granulocytes was not
observed in spite of the upregulation of C/EBPb (Figure 4B, 4C
and 4D). In the presence of GM-CSF, C/EBPb might be already
fully activated for induction of granulocytic differentiation.
Therefore, further upregulation of C/EBPb by extrinsically
introduced constitutively active CREB failed to cause further
increase of Gr-1
+ cells.
The connection between CREB proteins and C/EBPb has also
been observed in other tissues. In hepatocytes, CREB proteins
regulate C/EBPb transcription through the CREs in response to
lipopolysaccharides (LPS) stimulation [24] or during liver regen-
eration after partial hepatectomy [25]. During the mitotic clonal
expansion of adipocytes, a process of early adipocyte differenti-
ation, C/EBPb is also under the control of CREB [26]. In
hematopoietic systems, C/EBPb is transcriptionally upregulated in
monocytes and macrophages when they are activated by LPS
[27,28]. Here, we showed the involvement of CREB-C/EBPb
connection in granulopoiesis for the first time.
There are two classes of CREs, asymmetric and weak binding
sites and symmetrical sites with higher binding affinity. Constitu-
tive binding of CREBs is observed in the symmetrical CREs and
phosphorylation-dependent binding is specific to the asymmetric
and weak binding sites [29]. Both of the CREs in the C/EBPb
promoter are the asymmetric and weak binding sites. The CRE
sites in the promoter region of C/EBPb are conserved from
Xenopus to human [25,27,30,31], suggesting that the transcriptional
regulation of C/EBPb by CREB is a fundamental biological
process required for the maintenance of homeostasis under various
stress conditions.
In patients with congenital neutropenia (CN), steady state
granulopoiesis driven by lymphoid enhancer-binding factor (LEF-
1) and C/EBPa is almost abrogated [32], and treatment of these
patients with G-CSF triggered C/EBPb-dependent emergency
granulopoiesis, which resembled the C/EBPa-independent and
C/EBPb-dependent ‘emergency’ granulopoiesis previously ob-
served in a mouse model. [4] In a subset of leukemia cells,
impairment of the function or expression of C/EBPa results in a
differentiation block in leukemic blast cells [33–35], which might
possibly be reversed by the upregulation of C/EBPb [36]. Here,
CREBs-mediated transcriptional activation of C/EBPb was shown
as one of the switching mechanism for ‘emergency’ granulopoiesis.
Recent reports have demonstrated that STAT3 and sirtuin-1 were
also involved in the upregulation of C/EBPb during granulopoi-
esis under stressed conditions [37–38]. Further elucidation of the
molecular mechanisms regulating C/EBPb will facilitate the
improvement of therapies for treating patients with diseases in
which C/EBPa is dysregulated, such as CN and leukemia.
In this study, we showed that CREB proteins are involved in the
regulation of granulopoiesis through the transcriptional upregula-
tion of C/EBPb, suggesting that CREB is a molecular switch
required for C/EPBb-dependent granulopoiesis. In addition, the
novel lentivirus vector-based reporter system will facilitate the
analysis of gene regulatory elements in primary cells.
Materials and Methods
Ethics Statement
All procedures using animals were reviewed and approved by
the Kyoto Prefectural University of Medicine Animal Research
Committee (Permit Number: M18-55).
Mice
C57BL/6 mice were purchased from Shimizu Laboratory
Animals (Kyoto, Japan) or Clea Japan (Tokyo, Japan). We took all
necessary steps to minimize suffering of mice during the
experiments.
Infection with Candida Albicans
Systemic infection with Candida albicans were carried out as
previously described [4,18,19]. Briefly, Candida albicans (18804;
American Type Culture Collection) was plated onto Luria-Bertani
broth agar plates and the plates were stored at 4uC for a maximum
of 4 weeks. Before each experiment, several colonies were picked
from the plate and grown in 3 mL of Sabouraud dextrose broth
(Sigma Aldrich, St. Louis, MO) at 37uC for 24 h. The fungi were
washed twice with pyrogen-free phosphate-buffered saline (PBS),
re-suspended in PBS, and 4610
6 CFU/20 g body weight/mouse
were intravenously injected via the tail vein to induce disseminated
candidiasis.
Cell Lines
NIH3T3 cells (ATCC) were cultured in Dulbecco’s modified
Eagle’s medium (Wako, Japan) supplemented with 10% fetal
bovine serum at 37uCi n5 %C O 2.
the promoter region of C/EBPb and nuclear extracts of 293T cells transduced with constitutively active CREB. Data are representative of two
independent experiments.
doi:10.1371/journal.pone.0054862.g003
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A 1109-bp region from the proximal promoter (21093 bp to
+16 bp; transcription start site: +1 bp) of C/EBPb was amplified
by PCR using the following genomic DNA primers: forward,
cggaattcacgcgtggttgagcaacaccccaccagcttgccggggc; reverse,
ccgctcgaggtcccgtgcgcggctcggactcggctcggcgg. The PCR product
was cloned into the EcoRI and XhoI sites of a pBluescript plasmid
vector. A series of deletion variants of the promoter (2863/
+16 bp, 2243/+16 bp and 243/+16 bp) were generated by
removing the fragments between AatI/BstEII, AatI/NheIo rAatI/
NarI, respectively, and allowing the vector to religate. Mutations
that disrupt the CRE sites at 2110 bp and 265 bp of the
promoter were generated by PCR-based, site-directed mutagenesis
as previously described [39] and changed the sequence at each site
from TGACG to ACTCG. [25]. The introduced mutations and
the integrity of non-mutated regions were confirmed by sequenc-
ing of cloned PCR products.
Lentivirus Vectors
Two expression units, i) a destabilized variant of the enhanced
green fluorescent protein (d2EGFP derived from the pd2EGFP
vector, Clontech, CA), and ii) the mouse Thy1.1 gene under the
control of the phosphoglycerate kinase (PGK) promoter, were
flanked by an MluI-EcoRI CS-CDF-EG-PRE fragment (Riken
BioResource Center) and an XbaI-MluI CS-II-Ars(-) fragment [11]
to form the lentivirus vector, CS-PGKThy-d2G-MCS. The
various C/EBPb promoter sequences between EcoRI and XhoIi n
pBluescript were cloned into the multi cloning site of CS-
PGKThy-d2G-MCS.
CREB Mutants
Plasmid vectors containing CREB
S133A (pNN LBDCREB
S133A)
[17], a dominant negative CREB mutant, and CREB
DIEDML
(pRC/RSV FLAG CREB
DIEDML) [14], a constitutively-active
CREB mutant, were kind gifts from Dr. S. Kida and Dr. R. H.
Goodman, respectively. These mutants were fused to the ligand-
binding domain of the estrogen receptor and hemagglutinin virus
(HA)-tag sequence and cloned into the MSCV-IRES-GFP vector.
Lentivirus and Retrovirus Infection
Viral supernatants were collected as previously described [40]
(see also http://www.brc.riken.jp/lab/cfm/
Subteam_for_Manipulation_of_Cell_Fate/Protocols.html). Bone
marrow cells were harvested from 5-fluorouracil–treated mice
and cultured in the presence of stem cell factor (10 ng/ml),
interleukin (IL)-3 (10 ng/ml) and IL-6 (10 ng/ml) for two days.
Viral infection was carried out twice during the following two days
with 4 mg/ml of polybrene. Cells were analyzed by flow cytometry
after a further two days culture in the presence of granulocyte-
macrophage-colony–stimulating factor (GM-CSF) (10 ng/ml,
R&D systems, MN). Transduction efficiency was around 10%
(4–30%) and was dependent on the length of the promoter
inserted in the vectors and on the transduction condition.
Detection of Phosphorylated CREB by Flow Cytometry
After 1 hour of stimulation with GM-CSF, bone marrow cells
were fixed with 20 volumes of prewarmed BD Phosflow Lyse/Fix
buffer (BD Bioscience, CA), incubated at 37uC for 10 minutes,
permeabilized with BD Phosflow Perm III (BD Bioscience, CA),
and incubated on ice for 30 minutes. Permeabilized cells were then
Figure 4. Effects of dominant negative and constitutively-active forms of CREB on GM-CSF–induced granulopoiesis. A. Western
blotting of nuclear extracts from NIH3T3 cells retrovirally transduced with hemmagulutinin (HA) tagged-CREB mutants in the presence or absence of
hydroxytamoxifen (4-OHT). TATA-binding protein (TBP) was used as an internal control of nuclear protein. B and C. Flow cytometric analysis of bone
marrow cells stimulated with GM-CSF in the presence or absence of hydroxytamoxifen after transduction with the indicated vectors. The percentages
of Gr-1
+GFP
+ cells for each experiment are shown in C. D. Expression of C/EBPb mRNA in sorted Gr-1
+GFP
+ cells transduced with the indicated
retrovirus vectors. *:P,005 (n=3). E. Western blotting of whole cell lysates of GFP
+ cells purified from bone marrow cells stimulated with GM-CSF in
the presence or absence of hydroxytamoxifen after transduction with the indicated vectors. F. Expression of mRNA of G-CSF receptor (G-CSFR) and
myeloperoxidase (MPO) in sorted Gr-1
+GFP
+ cells transduced with the indicated retrovirus vectors. *:P,005 (n=3). Data are representative of two or
three independent experiments.
doi:10.1371/journal.pone.0054862.g004
Figure 5. Involvement of CREB-C/EBPb pathway in candidemia-
induced ‘‘emergency granulopoiesis.’’ A. Expression of C/EBPb
mRNA in c-kit
+ bone marrow cells with or without candidemia.
*:P,0.05, n=3. B. Western blotting analysis of c-kit+ bone marrow
cells with or without candidemia. C. Chromatin immunoprecipitation of
CREB using c-kit+ bone marrow cells during candidemia induced
emergency granulopoiesis. Data are representative of two independent
experiments.
doi:10.1371/journal.pone.0054862.g005
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Bioscience, CA). Then, cells were stained with allophycocyanin
(APC)-conjugated anti c-kit antibody and Alexa FluorH 488-
conjugated anti phospho-CREB antibody (Cell Signaling Tech-
nology, MA).
Flow Cytometric Analysis
Mouse bone marrow cells were analyzed and sorted using a
FACSCalibur or FACSAria flow cytometer (BD Bioscience, CA).
Data were analyzed with FlowJo software (Tree Star Inc., OR).
Quantitative RT-PCR
Total RNA was extracted using the RNeasy Micro kit (Qiagen,
CA) and reverse-transcribed using random primers. The real-time
PCR was performed as previously described [41]. The real-time
PCR reaction mixture contained 4ml of Taqman master mix
(Roche Diagnostics GmbH Mannheim, Germany), cDNA, pairs of
primers and Taqman probe (Universal Probe Library, Roche
Diagnostics). The cDNA was amplified with a Light Cycler 3.5
(Roche Diagnostics) using the following parameters, 95uC for 10
minutes, followed by 45 cycles at 95uC for 10 seconds and 60uC
for 30 seconds. Glyceraldehyde-3-phosphate (GAPDH) was used
as an internal control with nuclease-free water as a negative
control. The sequences of the primers and probes are as follows:
CREB, forward primer: ccaaactagcagtgggcagt, reverse primer:
ccccatccgtaccattgtt, Roche Universal Probe #52; activating
transcription factor 1 (ATF1), forward primer: agagaaatacgact-
gatgaaaaacag, reverse primer: ttttcagaacagcaacacg, probe #80;
cyclic AMP responsive modulator (CREM), forward primer:
gctgaggctgatgaaaaaca, reverse primer: gccacacgattttcaagaca,
probe #4; C/EBPb, forward primer atcgacttcagcccctacct, reverse
primer: tagtcgtcggcgaagagg, probe #55; C/EBPa, forward primer
ccttcaacgacgagttcctg, reverse primer: tggccttctcctgctgtc, probe
#11; and GAPDH, forward primer: tgtccgtcgtggatctgac, reverse
primer: cctgcttcaccaccttcttg, probe #80.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation experiments were performed
using a Chip IT-Express kit according to the manufacturer’s
instructions (Active Motif, Rixensart, Belgium). For immunopre-
cipitation of the fragmented chromatin, an anti-CREB antibody
(48H2, Cell Signaling Technologies, MA) was used. The following
set of primers were used for the amplification of the genomic
fragment containing the two CREs in the proximal promoter
region of C/EBPb, forward: tcacccgcgtccgtg, reverse: gccgagcgg-
gaggttta.
Western Blotting
Cells were diluted with Laemmli sample buffer and boiled at
100uC for 10 min. Samples were separated by SDS-PAGE and
transferred to polyvinylidene fluoride membranes. Antibodies
specific for C/EBPb (sc-150, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), CREB (sc-25785, Santa Cruz Biotechnology),
TBP (sc204, Santa Cruz Biotechnology), HA (sc-805, Santa Cruz
Biotechnology) and GAPDH (sc-25778, Santa Cruz Biotechnol-
ogy) were used as primary antibodies. Immunoreactive proteins
were detected using horseradish peroxidase-conjugated anti-rabbit
IgG (NA934V, GE Healthcare, Little Chalfont, UK) and
visualized using enhanced chemiluminescence (ECL, GE Health-
care).
Gel Shift Assay
Nuclear ectracts from transduced 293T cells were isolated with
NE-PER
TM kit according to the manufacturer’s instructions
(Pierce, Rockland, IL) and the LightShift Chemiluminescent
Electrophoretic Mobility Shift Assay Kit was used for detection
of DNA-protein interaction. CRE sites oligonuculeotides con-
tained the following sequences: CRE at 2110 bp, 59-GGGCAAT-
GACGCGCACCGACCG-39; CRE at 265 bp, 59-CCAGCGT-
GACGCAGCCCGTTGC-39; consensus CREB binding sites, 59-
AGAGATTGCCTGACGTCAGAGAGCTAG-39. Binding reac-
tion was performed on ice for 20 min (0.2 mM biotin-labeled
oligonucleotide probe, 16binding buffer, 150 mmol/L KCl,
0.1 mmol/L EDTA, 2.5 mmol/L DTT, 0.05% NP40, 10%
glycerol, and 50 ng/mL poly[dI-dC]).
Statistical Analysis
Statistical differences were determined by the Student’s t test. P
values ,0.05 were considered statistically significant.
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